Vicente Aguayo-Herrero
Cordoba, AN 14004, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
miR-191-5p: A tumour suppressor miRNA and a personalized biomarker and potential therapeutic tool connecting prostate cancer and obesity.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 01, 2025
Inflammasomes: Cause or consequence of obesity-associated comorbidities in humans.
Journal: Obesity (Silver Spring, Md.)
Published: February 05, 2022
Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool.
Journal: Molecular therapy. Nucleic acids
Published: November 15, 2021
HIF-2α Preserves Mitochondrial Activity and Glucose Sensing in Compensating β-Cells in Obesity.
Journal: Diabetes
Published: August 18, 2021
Comparative Cytotoxic Activity of Hydroxytyrosol and Its Semisynthetic Lipophilic Derivatives in Prostate Cancer Cells.
Journal: Antioxidants (Basel, Switzerland)
Published: June 30, 2021
Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 17, 2021
Dysregulation of Components of the Inflammasome Machinery After Bariatric Surgery: Novel Targets for a Chronic Disease.
Journal: The Journal of clinical endocrinology and metabolism
Published: March 31, 2021
Clinical, Cellular, and Molecular Evidence of the Additive Antitumor Effects of Biguanides and Statins in Prostate Cancer.
Journal: The Journal of clinical endocrinology and metabolism
Published: November 23, 2020
Influence of Obesity in the miRNome: miR-4454, a Key Regulator of Insulin Response Via Splicing Modulation in Prostate.
Journal: The Journal of clinical endocrinology and metabolism
Published: August 19, 2020
Unleashing the Diagnostic, Prognostic and Therapeutic Potential of the Neuronostatin/GPR107 System in Prostate Cancer.
Journal: Journal of clinical medicine
Published: April 24, 2020
Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer.
Journal: Journal of clinical medicine
Published: October 15, 2019
Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate Cancer.
Journal: Journal of clinical medicine
Published: August 20, 2019
Last Updated: 09/26/2026